Jefferies Group’s Dynavax Technologies DVAX Stock Holding History

Jefferies Group’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$377K	Hold	36,100	–	–	﹤0.01%	1138
2022 Q2	$454K	Sell	36,100 -27,900	-44%	-$296K	﹤0.01%	1035
2022 Q1	$694K	Hold	64,000	–	–	﹤0.01%	970
2021 Q4	$900K	Hold	64,000	–	–	0.01%	1025
2021 Q3	$1.23M	Buy	+64,000	New	+$850K	0.01%	916
2018 Q1	–	Sell	-36,900	Closed	-$690K	–	2326
2017 Q4	$690K	Sell	36,900 -29,500	-44%	-$592K	﹤0.01%	1574
2017 Q3	$1.43M	Buy	+66,400	New	+$1.05M	0.01%	1108
2017 Q1	–	Sell	-103,800	Closed	-$410K	–	2403
2016 Q4	$410K	Sell	103,800 -47,100	-31%	-$345K	﹤0.01%	1662
2016 Q3	$1.58M	Buy	+150,900	New	+$2.17M	0.01%	1048

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's DVAX Position: Q3 2022 in Review

Jefferies Group increased its Dynavax Technologies (DVAX) stake by 1,175% in Q3 2022, buying an estimated $75K and bringing the position to 6,246 shares worth $65.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Jefferies Group first reported a position in DVAX in Q2 2015 and has held it in 16 quarters since. The position peaked at $219K in Q3 2021. 236 funds tracked by Wall St. Rank hold DVAX as of Q3 2022.

Jefferies Group held 6,246 shares of Dynavax Technologies worth $65.2K as of Q3 2022.
Jefferies Group bought 5,756 Dynavax Technologies shares in Q3 2022, an estimated $75K.
Dynavax Technologies made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1498 holding.
Jefferies Group first reported a position in Dynavax Technologies in Q2 2015 and has held it in 16 quarters since.
Jefferies Group's Dynavax Technologies position peaked at $219K in Q3 2021.
236 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.